Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Input: Consider Input: The health department said at least 16 patients admitted to the 210-bed Mount Carmel Grove City hospital after its opening April 28 have been diagnosed with Legionnaires'. The disease is a severe form of pneumonia that's caused by inhaling tiny water droplets containing the legionella bacteria. One of the patients, a 75-year-old woman, died. Hospital president Sean McKibben said in a statement Thursday that the disease outbreak happened because of inadequate disinfection of the hot water system prior to the hospital's opening. He said a permanent supplemental disinfection system with constant monitoring and controls has been installed. ___ Information from: The Columbus Dispatch, http://www.dispatch.com

Output: Outbreak of Legionnaire's blamed on hot water system.

Input: Consider Input: In a study in the medical journal The Lancet, they said the patients, with strains of TB known as extensively-drug resistant (XDR) and totally drug resistant (TDR) TB, have exhausted all available treatment options and are sent home. "These patients can survive for months or even years and are contributing to the community-based spread of XDR-TB," said Keertan Dheda, who led the study at the University of Cape Town's department of medicine. Tuberculosis infects the lungs and can spread through coughing and sneezing. In recent years, drug-resistant strains have spread around the world, batting off standard antibiotics and posing an increasingly urgent public health threat. The World Health Organization (WHO) estimates that in Eastern Europe, Asia and South Africa, 450,000 people have MDR-TB, and around half of these will fail to respond to existing treatments. Dheda's team followed 107 patients with XDR-TB from three provinces in South Africa between March 2008 and August 2012 to establish their fate. They also took samples from 56 patients and tested them to find out which and how many of 10 first- and second-line anti-TB drugs they were susceptible to. Despite being treated intensively with an average of eight anti-tuberculosis drugs, many of the patients fared poorly, with high rates of treatment failure and death. Five years after treatment initiation, only 12 of the patients had favorable outcomes and 74 percent had died. The researchers found that almost two-thirds of the tested patients had resistance to at least eight drugs, and there was one case of totally drug-resistant TB that was not susceptible to any of the 10 drugs tested. More worrisome, Dheda said, was that of the XDR-TB patients discharged into the general community, some 42 percent had failed to get better on treatment and were testing positive for active TB, and of these almost a third were at high risk of transmitting the disease. The patients also survived in the community for an average of 20 months - plenty of time to infect others. When people with lung TB cough, sneeze or spit, they propel the TB germs into the air. Another person needs to inhale only a few of these germs to become infected. "Alarmingly, we have shown for the first time that... treatment failure and discharge of such patients into the wider community is occurring systematically on a country-wide level in South Africa," Dheda said in a statement about the findings. In one case where the researchers followed a genetic trail of transmission, they found that a patient with XDR-TB who was discharged after failing treatment went on to infect his brother, who also eventually died. Dheda said the reason many TB patients are being sent away from hospitals appeared to be lack of bed space in designated tuberculosis hospitals. "And alternative long-term residential and palliative care facilities are scarce." Commenting on the findings in The Lancet, Max O'Donnell from New York's Albert Einstein College of Medicine in the United States said they should serve as an "urgent alarm". "MDR-TB (multi-drug-resistant TB) in all its forms is an out-of-control problem with potentially vast and devastating consequences for global public health," he wrote. "The situation regarding MDR and XDR-TB is bleak."

Output: South Africa risks spreading totally drug-resistant TB: study.

Input: Consider Input: Everett, a working-class city of about 108,000 north of Seattle, sued Connecticut-based Purdue Pharma in January, alleging the company knowingly allowed pills to be funneled into the black market and into the city and did nothing to stop it. Purdue filed a motion to dismiss in March. Before hearing arguments Monday, U.S. District Court Judge Ricardo S. Martinez called the case an interesting one with some novel legal issues. Purdue attorney Patrick Fitzgerald told the judge the case should be tossed for a number of reasons. Among them, the city fails to show a direct relationship between the company's conduct and the alleged harms. "It's a textbook example of remoteness," Fitzgerald said. He argued there are nine steps including wrongdoing by pharmacies and criminal gangs between Purdue's conduct and the expenses the city incurred in responding to the problems of opioid addiction. The lawyer for the city, Christopher Huck, told the judge that emails and other internal documents show that Purdue knowingly put their painkillers into a supply chain they knew ended at an organized drug ring, and the city has suffered for it. The city should be allowed to make its case at trial, he said. "OxyContin has devastated the community and inflicted enormous harm," said Huck, who was joined at the table by Everett Mayor Ray Stephanson. The injury here is the diversion and misuse of OxyContin and the damages is what the city had had to deal with that harm, Huck said. Three city council members, the police chief and others filled the benches in the courtroom Monday. "Our city has been significantly damaged. Obviously, we hope the case is not dismissed and goes forward on its merits," the mayor said outside the courtroom. "Our community needs help. And clearly we believe our city has been damaged by this crisis." Purdue knew their pills were going into the black market, had an obligation to report it and they didn't do that, Stephanson said. Fitzgerald argued in court that there's no proof Purdue was dealing to drug dealers and noted that Purdue provided pills to a wholesaler. The company argued Monday that the statute of limitations has passed for the city to file the lawsuit. In court documents, it also argued that city can't hold it responsible for illegal trafficking when law enforcement officials knew and were already investigating criminal trafficking at issue. The lawsuit doesn't say how much money the city is seeking. Stephanson said that will be determined in the weeks and months to come. Everett filed its lawsuit after the Los Angeles Times reported that Purdue had evidence that pointed to illegal trafficking of its pills but in many cases did nothing to notify authorities or stop the flow. That newspaper investigation prompted the city's lawsuit. Last week, a second city in Washington state, Tacoma, sued Purdue Pharma and two other opioid manufacturers, Endo Health Solutions and Janssen Pharmaceuticals. That lawsuit alleges the companies made false and misleading statements about the benefits and risks of opioids to doctors and patients over the past two decades. ___ Information from: The Daily Herald, http://www.heraldnet.com
Output: City asks judge to let case against OxyContin maker proceed.